Changes have come to The Blood-Horse sire lists. Beginning with this issue, the statistics populating the sire lists will be slightly different to reflect shifts in racing and the commercial marketplace...
Read More
In a column that ran in The Blood-Horse ’s March 29, 2014, issue, we addressed the breaking scandal involving a video released and published by People for the Ethical Treatment of Animals (PETA). At the...
Read More
What happened to a Thoroughbred after it finished racing barely registered as an issue with most industry stakeholders 25 years ago. “Nobody cared,” said Delaware owner/breeder Herb Moelis, a New York...
Read More
The recent New York Thoroughbred Horsemen’s Association election has raised some troubling questions about how horsemen’s organizations are run and also has exposed at least one major pitfall in the ability...
Read More
Egregious. Disgusting. Ugly. These and many much harsher words sailed through social media channels following the Breeders’ Cup Classic (gr. I) Nov. 1 at Santa Anita Park. The highly anticipated showdown...
Read More
Innovation and commitment to excellence were honored Sept. 28 at the Thoroughbred Club of America’s 83rd Annual Testimonial Dinner. Three veterinarian pioneers—Dr. Edward Fallon, Dr. Gary Lavin, and Dr...
Read More
The median tells the tale of the market’s health at the Keeneland September sale to date. Forget the number of horses that sell for $1 million or more, even though they provide the sizzle to the world...
Read More
Here’s Shared Belief poised to steal the show once again. After the Triple Crown, conventional wisdom had all but conceded 3-year-old male championship honors to California Chrome. The argument for draping...
Read More
As part of the ongoing debate about the future of medication testing and enforcement in American racing, let’s hope out-of-competition testing takes on a greater sense of urgency. Being able to test a...
Read More
A stance by 25 prominent American trainers Aug. 1 urging the elimination of race-day Salix over the next two years has not done much to clarify the debate over the medication’s use (see page 15), but it...
Read More